BIAMUS

Pharmaceuticals for medical purposes used to maintain health or restore health to a human or animal subject through treatment of a disturbed microbial community; dietary and nutritional supplements; nutritional food additives for medical purposes in the nature of microorganisms derived from animals, including humans; diagnostic agents for medical purposes for assessing whether a human or animal subject has a disturbed microbial community; biological preparations in the nature of microorganisms for medical purposes used to maintain health or restore health to a human or animal subject through treatment of a disturbed microbial community; cultures and preparations of microorganisms for medical and veterinary purposes; Pharmaceutical and biopharmaceutical agents, namely, microbiologics, immunotherapeutics, and other therapeutic agents, for the prevention and treatment of human diseases, namely, infectious disease, autoimmune disease, inflammatory disease, immune disorders, allergic disorders, cancer, immuno-oncology, metabolic disorders, digestive disorders, neurological disorders, and cardiovascular disorders; Pharmaceuticals in the nature of cultures of microorganisms for medical and veterinary use